Has Zaina Shahid, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,508 in general payments to Zaina Shahid, MD across 109 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Zaina Shahid, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Zaina Shahid, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Zaina Shahid, MD

Rheumatology · Wexford, PANPI 1073171898

Payments from drug & device makers

$2,508in general payments, 2019–2025

Across 109 payments — averaging $23.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$603
Amgen$406
AbbVie$312
Novartis$243
AstraZeneca$197
GSK$143
plus $603 from 13 others

What the payments were for

Food & beverage$2,24590%
Education$26310%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	16	$603
Amgen	17	$406
AbbVie	18	$312
Novartis	14	$243
AstraZeneca	9	$197
GSK	7	$143
UCB, Inc.	5	$117
Lilly USA, LLC	4	$92
Aurinia Pharma U.S., Inc.	2	$77
E.r. Squibb & Sons, L.L.C.	3	$62
Pfizer	2	$41
Sobi, Inc	2	$39
Boehringer Ingelheim	2	$34
Fresenius Kabi USA, LLC	2	$33
Organon	2	$33
Sandoz	1	$25
Kiniksa Pharmaceuticals International, PLC	1	$20
Genentech USA, Inc.	1	$16
Kiniksa Pharmaceuticals, Ltd.	1	$15

How this compares

$2,508 in reported general payments places this provider in the 45th percentile of 351 rheumatology providers in Pennsylvania.

See all rheumatology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$4,202

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Enbrel SureclickEtanercept	11	$84,148
Hydroxychloroquine Sulfate	83	$2,243
MethotrexateMethotrexate Sodium	43	$1,453
Colchicine	27	$1,393
Prednisone	61	$348
Alendronate Sodium	27	$326
Allopurinol	18	$104
Meloxicam	11	$11

Paid to pharmacies, not to this prescriber.

Other rheumatology in Wexford

Alan KivitzDuncansville$27.1M
Peter MerkelRadnor$6.3M
Rohit AggarwalPittsburgh$6.2M
Alexis Ogdie-BeattyPhiladelphia$5.7M
Jonathan MinerPhiladelphia$3.8M
Siamak Moghadam-KiaPittsburgh$1.9M
Frederick MurphyDuncansville$1.2M
Gregory EmkeyWyomissing$1.2M
Alan EpsteinPhiladelphia$1.2M
Lawrence LeventhalHuntingdon Valley$1.1M

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →